Orthofix Medical (OFIX) Competitors

Orthofix Medical logo
$6.34 -0.27 (-4.08%)
Closing price 04:00 PM Eastern
Extended Trading
$6.34 0.00 (-0.08%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OFIX vs. MMSI, SIBN, IART, IRMD, and ATEC

Should you buy Orthofix Medical stock or one of its competitors? Orthofix Medical's main competitors and comparable companies include Merit Medical Systems (MMSI), SiBone (SIBN), Integra LifeSciences (IART), iRadimed (IRMD), and Alphatec (ATEC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Orthofix Medical compare to Merit Medical Systems?

Orthofix Medical (NASDAQ:OFIX) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 2.7% of Orthofix Medical shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Orthofix Medical has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

Merit Medical Systems has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.31-$92.19M-$1.12N/A
Merit Medical Systems$1.52B3.34$128.49M$2.6631.73

Orthofix Medical currently has a consensus price target of $13.50, suggesting a potential upside of 112.93%. Merit Medical Systems has a consensus price target of $105.91, suggesting a potential upside of 25.47%. Given Orthofix Medical's higher probable upside, research analysts plainly believe Orthofix Medical is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Merit Medical Systems
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62

Merit Medical Systems has a net margin of 9.94% compared to Orthofix Medical's net margin of -5.39%. Merit Medical Systems' return on equity of 14.12% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-5.39% -10.32% -5.19%
Merit Medical Systems 9.94%14.12%8.37%

In the previous week, Merit Medical Systems had 6 more articles in the media than Orthofix Medical. MarketBeat recorded 8 mentions for Merit Medical Systems and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.64 beat Merit Medical Systems' score of 0.54 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Merit Medical Systems
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Merit Medical Systems beats Orthofix Medical on 12 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to SiBone?

Orthofix Medical (NASDAQ:OFIX) and SiBone (NASDAQ:SIBN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Orthofix Medical has a net margin of -5.39% compared to SiBone's net margin of -6.20%. SiBone's return on equity of -7.57% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-5.39% -10.32% -5.19%
SiBone -6.20%-7.57%-5.55%

In the previous week, SiBone had 12 more articles in the media than Orthofix Medical. MarketBeat recorded 14 mentions for SiBone and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.64 beat SiBone's score of 0.41 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
SiBone
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Orthofix Medical has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market. Comparatively, SiBone has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

Orthofix Medical currently has a consensus target price of $13.50, indicating a potential upside of 112.93%. SiBone has a consensus target price of $25.00, indicating a potential upside of 5.26%. Given Orthofix Medical's higher probable upside, research analysts plainly believe Orthofix Medical is more favorable than SiBone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
SiBone
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

SiBone has lower revenue, but higher earnings than Orthofix Medical. SiBone is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.31-$92.19M-$1.12N/A
SiBone$200.93M5.33-$18.90M-$0.31N/A

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by company insiders. Comparatively, 4.0% of SiBone shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

SiBone beats Orthofix Medical on 9 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to Integra LifeSciences?

Orthofix Medical (NASDAQ:OFIX) and Integra LifeSciences (NASDAQ:IART) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

In the previous week, Integra LifeSciences had 1 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for Integra LifeSciences and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.64 beat Integra LifeSciences' score of 0.00 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Integra LifeSciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Integra LifeSciences has a net margin of 0.79% compared to Orthofix Medical's net margin of -5.39%. Integra LifeSciences' return on equity of 18.63% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-5.39% -10.32% -5.19%
Integra LifeSciences 0.79%18.63%5.49%

Orthofix Medical has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market.

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 2.7% of Orthofix Medical shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Orthofix Medical has higher earnings, but lower revenue than Integra LifeSciences. Orthofix Medical is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.31-$92.19M-$1.12N/A
Integra LifeSciences$1.64B0.64-$516.47M$0.1779.71

Orthofix Medical presently has a consensus target price of $13.50, suggesting a potential upside of 112.93%. Integra LifeSciences has a consensus target price of $16.13, suggesting a potential upside of 19.00%. Given Orthofix Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Orthofix Medical is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Integra LifeSciences
3 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.90

Summary

Integra LifeSciences beats Orthofix Medical on 10 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to iRadimed?

iRadimed (NASDAQ:IRMD) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends.

In the previous week, iRadimed had 1 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for iRadimed and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.64 beat iRadimed's score of 0.96 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRadimed
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

iRadimed has a net margin of 26.85% compared to Orthofix Medical's net margin of -5.39%. iRadimed's return on equity of 23.90% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
iRadimed26.85% 23.90% 20.89%
Orthofix Medical -5.39%-10.32%-5.19%

iRadimed has higher earnings, but lower revenue than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRadimed$83.81M12.40$22.48M$1.8743.45
Orthofix Medical$822.31M0.31-$92.19M-$1.12N/A

iRadimed presently has a consensus price target of $120.00, indicating a potential upside of 47.67%. Orthofix Medical has a consensus price target of $13.50, indicating a potential upside of 112.93%. Given Orthofix Medical's higher possible upside, analysts plainly believe Orthofix Medical is more favorable than iRadimed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRadimed
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

iRadimed has a beta of 0.91, meaning that its stock price is 9% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

92.3% of iRadimed shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 34.6% of iRadimed shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

iRadimed beats Orthofix Medical on 13 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to Alphatec?

Alphatec (NASDAQ:ATEC) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

In the previous week, Alphatec had 19 more articles in the media than Orthofix Medical. MarketBeat recorded 21 mentions for Alphatec and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.64 beat Alphatec's score of -0.51 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Negative
Orthofix Medical
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Orthofix Medical has a net margin of -5.39% compared to Alphatec's net margin of -10.35%. Orthofix Medical's return on equity of -10.32% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-10.35% -6,752.24% -9.77%
Orthofix Medical -5.39%-10.32%-5.19%

Alphatec presently has a consensus target price of $15.37, indicating a potential upside of 122.71%. Orthofix Medical has a consensus target price of $13.50, indicating a potential upside of 112.93%. Given Alphatec's stronger consensus rating and higher possible upside, research analysts clearly believe Alphatec is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Orthofix Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$764.16M1.40-$143.36M-$0.55N/A
Orthofix Medical$822.31M0.31-$92.19M-$1.12N/A

Alphatec has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market.

66.4% of Alphatec shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Comparatively, 2.7% of Orthofix Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Alphatec beats Orthofix Medical on 8 of the 15 factors compared between the two stocks.

Get Orthofix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OFIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OFIX vs. The Competition

MetricOrthofix MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$269.42M$5.92B$7.59B$11.70B
Dividend YieldN/A1.69%2.48%4.65%
P/E Ratio-5.6635.5231.9526.73
Price / Sales0.315.328.405.55
Price / CashN/A23.4220.7221.66
Price / Book0.604.154.423.65
Net Income-$92.19M$143.14M$3.51B$394.00M
7 Day Performance-8.65%-5.25%-6.16%-6.39%
1 Month Performance-33.89%-5.76%-7.05%-8.77%
1 Year Performance-56.15%-1.61%-2.52%-8.48%

Orthofix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OFIX
Orthofix Medical
3.9874 of 5 stars
$6.34
-4.1%
$13.50
+112.9%
-54.1%$269.42M$822.31MN/A1,605
MMSI
Merit Medical Systems
4.1985 of 5 stars
$87.81
-0.7%
$105.55
+20.2%
+2.1%$5.26B$1.52B33.017,500
SIBN
SiBone
1.914 of 5 stars
$25.10
-2.0%
$25.00
-0.4%
+28.2%$1.13B$200.93MN/A376
IART
Integra LifeSciences
1.9333 of 5 stars
$14.53
+1.1%
$16.13
+11.0%
+21.4%$1.13B$1.64B85.474,427
IRMD
iRadimed
3.2885 of 5 stars
$86.72
-0.3%
$120.00
+38.4%
-4.5%$1.11B$83.81M46.37166

Related Companies and Tools


This page (NASDAQ:OFIX) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners